Role of the gut microbiome in uremia: a potential therapeutic target

A Ramezani, ZA Massy, B Meijers, P Evenepoel… - American Journal of …, 2016 - Elsevier
Also known as the “second human genome,” the gut microbiome plays important roles in
both the maintenance of health and the pathogenesis of disease. The symbiotic relationship …

Metabolomics for clinical use and research in chronic kidney disease

B Hocher, J Adamski - Nature Reviews Nephrology, 2017 - nature.com
Chronic kidney disease (CKD) has a high prevalence in the general population and is
associated with high mortality; a need therefore exists for better biomarkers for diagnosis …

Protein nutrition and malnutrition in CKD and ESRD

Y Zha, Q Qian - Nutrients, 2017 - mdpi.com
Elevated protein catabolism and protein malnutrition are common in patients with chronic
kidney disease (CKD) and end-stage renal disease (ESRD). The underlying etiology …

Gut microbiome in chronic kidney disease: challenges and opportunities

A Nallu, S Sharma, A Ramezani, J Muralidharan… - Translational …, 2017 - Elsevier
More than 100 trillion microbial cells that reside in the human gut heavily influence nutrition,
metabolism, and immune function of the host. Gut dysbiosis, seen commonly in patients with …

Epigenetic modification of nucleic acids: from basic studies to medical applications

Y Chen, T Hong, S Wang, J Mo, T Tian… - Chemical Society …, 2017 - pubs.rsc.org
The epigenetic modification of nucleic acids represents one of the most significant areas of
study in the field of nucleic acids because it makes gene regulation more complex and …

[HTML][HTML] Gene and protein expressions and metabolomics exhibit activated redox signaling and wnt/β-catenin pathway are associated with metabolite dysfunction in …

DQ Chen, G Cao, H Chen, D Liu, W Su, XY Yu… - Redox biology, 2017 - Elsevier
Abstract Changes in plasma concentration of small organic metabolites could be due to their
altered production or urinary excretion and changes in their urine concentration may be due …

The gut microbiota and its relationship with chronic kidney disease

C Plata, C Cruz, LG Cervantes, V Ramirez - International Urology and …, 2019 - Springer
Chronic kidney disease (CKD) is a worldwide health problem, because it is one of the most
common complications of metabolic diseases including obesity and type 2 diabetes …

[HTML][HTML] Metabolomics insights into activated redox signaling and lipid metabolism dysfunction in chronic kidney disease progression

H Chen, G Cao, DQ Chen, M Wang, ND Vaziri… - Redox Biology, 2016 - Elsevier
Early detection is critical in prevention and treatment of kidney disease. However currently
clinical laboratory and histopathological tests do not provide region-specific and accurate …

Metabolomics and gene expression analysis reveal down-regulation of the citric acid (TCA) cycle in non-diabetic CKD patients

S Hallan, M Afkarian, LR Zelnick, B Kestenbaum… - …, 2017 - thelancet.com
Chronic kidney disease (CKD) is a public health problem with very high prevalence and
mortality. Yet, there is a paucity of effective treatment options, partly due to insufficient …

Urinary metabolite profiling and risk of progression of diabetic nephropathy in 2670 individuals with type 1 diabetes

S Mutter, E Valo, V Aittomäki, K Nybo, L Raivonen… - Diabetologia, 2022 - Springer
Aims/hypothesis This prospective, observational study examines associations between 51
urinary metabolites and risk of progression of diabetic nephropathy in individuals with type 1 …